OR WAIT null SECS
December 13, 2018
A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells.
September 28, 2018
A collaboration using Pall’s bioprocessing technology in G-CON’s PODs enables flexible continuous bioprocessing and viral vector facility solutions.
August 01, 2018
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
The quality of the cell lines used to manufacture biopharmaceuticals are crucial for the production of high-quality, stable biopharmaceuticals.
June 01, 2018
Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.
November 13, 2017
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
November 01, 2017
Anna Kireieva/Shutterstock.comSpeed to market is essential in the biopharmaceutical industry today.
October 12, 2017
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
December 01, 2016
The baculovirus-insect cell system can produce large quantities of complex protein in a short period of time.
September 01, 2016
The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.